Skip to main content

Bryan McIver, MD, PhD

Moffitt Cancer Tumor Center

Bryan McIver, MD, PhD, FRCP (Edin), is Deputy Physician in Chief at Moffitt Medical Group in Tampa, Florida. He received his medical degree from Edinburgh Medical School in Scotland and his PhD in Physiology and Biophysics at The University of Vermont in Burlington. Dr. McIver completed a residency in Internal Medicine at the Royal Infirmary of Edinburgh and a clinical fellowship and a clinical investigator fellowship in Endocrinology at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota.


Dr. McIver spent a number of years at the Mayo Clinic before joining the Moffitt Cancer Center in 2013, and he is currently responsible for the internal leadership of the Oncology clinical practice, including more than 600 physicians and advanced practice professionals. During his more than 20 years of clinical practice, he has gained broad experience in the evaluation and management of patients with thyroid nodules and cancer, with a particular focus on advanced and aggressive forms of thyroid cancer. Dr. McIver has a long-standing basic and translational research interest in the genetic regulation of growth, invasion, and spread of thyroid tumors of all types. His primary research focus is the use of genetic and molecular techniques to improve the accuracy of diagnosis of thyroid nodules, more accurately predict outcomes in the disease, tailor targeted treatment to a patient’s unique needs, and guide the use of novel therapies for progressive and life-threatening disease. Dr. McIver is a founding member of the World Congress on Thyroid Cancer, a biennial international meeting, now the largest such meeting in the world.